(R)-4-((9H-fluoren-9-yl)methoxy)-2-((tert-butoxycarbonyl)amino)-4-oxobutanoic acid, 97%, 5g

(S)-1-(4-(Trifluoromethyl)phenyl)ethanamine, 95.0%, 5g

tert-Butyl (5S)-5-methyl-1,4-diazepane-1-carboxylate, 98%, 100mg

7-Chloro-6-fluoro-1H-indole, 95%, 10g

Triethylene Glycol Monododecyl Ether>95.0%(GC)5mL

2-HYDROXY-2-METHYL-PROPIONAMIDINE HCL, 95.0%, 250mg

2-Phenyl-1 H -benzoimidazol-4-ylamine, 250mg

4-Chloro-3-hydroxybutanenitrile, 95%, 25g

4-ETHYNYL-1,1-DIFLUOROCYCLOHEXANE, 95%, 250mg

3-((2,5-Difluorophenyl)thio)butan-2-one, 95%, 100mg

4-Methoxyphenyl 4-((6-(acryloyloxy)hexyl)oxy)benzoate, 97.0%, 10g

4-NITROPHENYL [1,1'-BIPHENYL]-4-CARBOXYLATE, 95.0%, 250mg

Oxion OX.3065 Trinocular with Plan semi apo Fluarex 4x/10x/S40x/S100x oil IOS objectives and Abbe condenser